These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17554938)

  • 1. How aggressively should cholesterol targets be pursued?
    Wierzbicki AS
    Br J Hosp Med (Lond); 2007 May; 68(5):232-3. PubMed ID: 17554938
    [No Abstract]   [Full Text] [Related]  

  • 2. New American College of Cardiology and American Heart Association cholesterol treatment guidelines: subjects with Type 2 diabetes are under treated with high-intensity statins.
    Tripolt NJ; Sourij H
    Diabet Med; 2014 Jul; 31(7):879-80. PubMed ID: 24612178
    [No Abstract]   [Full Text] [Related]  

  • 3. The year in cardiology 2015: prevention.
    Chapman MJ; Blankenberg S; Landmesser U
    Eur Heart J; 2016 Feb; 37(6):510-9. PubMed ID: 26726043
    [No Abstract]   [Full Text] [Related]  

  • 4. Statins and the prevention of stroke in diabetes.
    Banerji MA
    Curr Diab Rep; 2005 Feb; 5(1):1-3. PubMed ID: 15663908
    [No Abstract]   [Full Text] [Related]  

  • 5. [Statin therapy].
    Hitzenberger G
    Wien Med Wochenschr; 2003; 153(11-12):242-3. PubMed ID: 12879631
    [No Abstract]   [Full Text] [Related]  

  • 6. Updated guidelines support even lower cholesterol levels for at-risk patients.
    Levenson D
    Rep Med Guidel Outcomes Res; 2004 Aug; 15(15):1, 6-7. PubMed ID: 15320342
    [No Abstract]   [Full Text] [Related]  

  • 7. Alternative approaches to cholesterol-lowering therapy.
    Grundy SM
    Am J Cardiol; 2002 Nov; 90(10):1135-8. PubMed ID: 12423718
    [No Abstract]   [Full Text] [Related]  

  • 8. [LDL cholesterol in cardiovascular risk patients should be as low as possible].
    MMW Fortschr Med; 2007 Oct; 149(41):44-5. PubMed ID: 17992793
    [No Abstract]   [Full Text] [Related]  

  • 9. [Statins remain the standard. New methods for lipid lowering therapy].
    Aumiller J
    MMW Fortschr Med; 2001 Oct; 143(42):16-7. PubMed ID: 11697281
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hyperlipidemia: decreasing lipid values and effects of statins].
    Mathes P
    Z Kardiol; 2002; 91 Suppl 2():25-9. PubMed ID: 12436762
    [No Abstract]   [Full Text] [Related]  

  • 11. LDL-Cholesterol is the King.
    Goumas GS
    Angiology; 2009; 60(3):387-8. PubMed ID: 19497926
    [No Abstract]   [Full Text] [Related]  

  • 12. [Recommended LDL value far lower. How does one achieve this goal?].
    Einecke D
    MMW Fortschr Med; 2004 Mar; 146(13):6. PubMed ID: 15219116
    [No Abstract]   [Full Text] [Related]  

  • 13. New developments in pharmacotherapy.
    Thompson GR
    Cardiovasc J S Afr; 2004; 15(2):56-8. PubMed ID: 15148538
    [No Abstract]   [Full Text] [Related]  

  • 14. A summary of implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1329-30. PubMed ID: 15297284
    [No Abstract]   [Full Text] [Related]  

  • 15. Pravastatin benefits elderly patients: results of PROSPER study.
    Cardiovasc J S Afr; 2003; 14(1):48. PubMed ID: 12728925
    [No Abstract]   [Full Text] [Related]  

  • 16. [Critical evaluation of indications for lipid reduction. Cholesterol value updated--risk counts (interview by Dr. Kirsten Westphal)].
    Motz W
    MMW Fortschr Med; 2003 Oct; 145(41):48. PubMed ID: 14655487
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison of cholesterol synthesizing enzymes (CSE) inhibitors].
    Ecker-Schlipf B
    Med Monatsschr Pharm; 1999 Jun; 22(6):184-6. PubMed ID: 10394795
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of lipids in patients with diabetes.
    Barnett A
    Diabetes Obes Metab; 2003 Nov; 5 Suppl 1():S3-9. PubMed ID: 14984016
    [No Abstract]   [Full Text] [Related]  

  • 19. [New statin introduction. With more power against hypercholesterolemia].
    MMW Fortschr Med; 2002 Dec; 144(50):64. PubMed ID: 14610873
    [No Abstract]   [Full Text] [Related]  

  • 20. Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption.
    Bruckert E; Giral P; Tellier P
    Circulation; 2003 Jul; 107(25):3124-8. PubMed ID: 12835406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.